BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11999580)

  • 1. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.
    Nasta SD; Carrum GM; Shahab I; Hanania NA; Udden MM
    Leuk Lymphoma; 2002 Feb; 43(2):423-6. PubMed ID: 11999580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy alone: a case report.
    Lim DH; Rhee JY; Park KW
    Int J STD AIDS; 2017 Aug; 28(9):932-936. PubMed ID: 28094666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations.
    Flaitz CM; Nichols CM; Walling DM; Hicks MJ
    Oral Oncol; 2002 Jan; 38(1):96-102. PubMed ID: 11755827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option.
    Klepfish A; Schattner A; Shvidel L; Shtalrid M; Haran M; Bentwich Z; Berrebi A
    Leuk Lymphoma; 2003 Feb; 44(2):349-51. PubMed ID: 12688356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
    Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
    Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
    Atallah-Yunes SA; Murphy D; Abdelmalak R; Mantle L; Ali SS
    Eur J Haematol; 2019 Dec; 103(6):620-622. PubMed ID: 31505061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein Barré virus-negative diffuse large B-cell lymphoma in an HIV-infected man with a durable complete remission on highly active antiretroviral therapy alone.
    Koszyk-Szewczyk A; Bayerl M; Zurlo J; Drabick JJ
    South Med J; 2010 Jan; 103(1):76-80. PubMed ID: 19996843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated plasmablastic lymphoma.
    Sharma R; Abdou S; Plymyer MR; Rohatgi C
    J Am Coll Surg; 2004 Oct; 199(4):654-5. PubMed ID: 15454154
    [No Abstract]   [Full Text] [Related]  

  • 10. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
    Foster WR; Bischin A; Dorer R; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute abdomen in an HIV-positive man.
    Reiter GS
    AIDS Clin Care; 1997 May; 9(5):41, 44. PubMed ID: 11364299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
    Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy.
    Sarkodee-Adoo C; Pittarelli L; Jaffe E; Sorbara L; Raffeld M; Yao X; Haddad R; Heller T
    Leuk Lymphoma; 2001; 42(5):1125-31. PubMed ID: 11697632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV-related multiple non-Hodgkin lymphomas].
    Gotoh M; Kitahara T; Iguchi T; Izumi M; Mukai K; Ohyashiki K
    Rinsho Ketsueki; 2008 Nov; 49(11):1552-5. PubMed ID: 19047787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic treatment response of cutaneous plasmablastic lymphoma in an HIV patient: a case report.
    Sakib SM; Sadler M
    Clin Imaging; 2016; 40(6):1067-1069. PubMed ID: 27408991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection.
    Riedel DJ; Gonzalez-Cuyar LF; Zhao XF; Redfield RR; Gilliam BL
    Lancet Infect Dis; 2008 Apr; 8(4):261-7. PubMed ID: 18353267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma.
    Wagner VP; Ortiz L; da Silva HP; Meurer L; da Cunha Filho JJ; Martins MA; Martins MD
    Indian J Dent Res; 2016; 27(5):559-562. PubMed ID: 27966518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.